Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained from mature female versus male animals

Endocrinology

Volumn 137, Issue 11, 1996, Pages 5174-5177

  Moraghan, T ^a   Antoniucci, D M ^a   Grenert, J P ^a   Sieck, G C ^b   Johnson, C ^a   Miller, V M ^a   Fitzpatrick, L A ^a  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF UROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HEART PROTECTION; HORMONAL REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0029803060     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.11.8895395     Document Type: Article

References (33)

1. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atherosclerosis in cholesterol-fed chicks receiving estrogens. Circulation 1951;4:468
2. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progesterone replacement therapy attenuate aortic accumulation of cholesterol in ovarectomized cholesterol -fed rabbits. J Clin Invest 1991; 87:1274-1279
3. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovarectomized monkeys. Arteriosclerosis 1990;10:1051-57
4. Furman RH. Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease? Ann NY Sci 1968;149:822-833
5. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63
6. Bush TL, Barret-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:89-104
7. Barr DP, Russ EM, Eder HA. Influence of estrogens on lipoproteins in atherosclerosis. Trans Assoc of Amer Physicians 1952;65:102-13
8. Severson AR, Ingram RT, Fitzpatrick LA. Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro. In Vitro, 31:853-857, 1995.
9. Srivatsa SS, Schwartz RS, Holmes Jr DR, Edwards WD, Park Y-K, Fitzpatrick LA. Coronary artery injury markedly upregulates matrix proteins mRNA following experimental balloon angioplasty. Clinical Research 42:180A, 1994.
10. Ingram RT, Park YK, Clarke BL, Fitzpatrick LA. Age and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone: Possible involvement of osteocalcin in bone remodeling. J Clin Invest 93:989-997, 1994.
11. Srivatsa SS, Edwards WD, Holmes DR Jr, Schwartz RS, Fitzpatrick LA. Upregulation of osteopontin mRNA following porcine balloon angioplasty. American College of Physicians, Miami FL, April 21, 1994.
12. Srivatsa SS, Fitzpatrick LA, Edwards WD, Simari RD, Schwartz RS. Neointimal formation in pigs and baboons: Both species express identical matrix protein mRNA in response to coronary artery injury. J Am Coll Cardiol, 419A, 803-1, 1995.
13. Srivatsa SS, Schwartz R, Edwards W, Johnson C, Fitzpatrick LA. Cellular expression of matrix proteins mediates calcification in native human and bioprosthetic heart valves. J Am Coll Cardiol, 33A:901-118, 1995.
14. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesion of atherosclerosis. Br Heart J 1993;69(supplement):S30-37
15. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen. Biochemical and Biophysical Research Communications 1993; Vol. 195, No. 2:730-736
16. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-1950
17. Ritchie CK, Maercklein PB, Fitzpatrick LA. Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations. Endocrinology 135:996-1003, 1994.
18. Bradford M. Analytic Biochem 1976;72:248.
19. Karas RH, Baur W, Tassi L, Mendelsohn ME. Inhibition of vascular smooth muscle cell growth by estrogen. Circulation 1993; vol. 88, No. 4, part 2; abstract from AHA 66th Scientific Session; I325
20. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwelt PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-617
21. Espinosa E, Luscher TF. 17 B estradiol inhibits proliferation of aortic smooth muscle cells: differential effects in male and female rats. Circulation 1994; vol. 9, #4, part 2:I87
22. Fischer-Dzoga K, Wissler RW, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Experimental and Molecular Pathology 1983;39:355-63
23. Perrot-Applanat M, Groyer-Picard MT, Garcia E, Lorenzo F, Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988; 123:1511-1519
24. Lobo RA. Estrogen and cardiovascular disease. Ann N Y Acad Sci 1990; 592:286-294,334-45
25. Sacks FM, Walsh BW. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci 1990;592:272-85
26. Makila UM, Wahlberg L, Viinikka L, Ylikorkala O. Regulation of prostacyclin and thromboxane production by human umbilical vessels: The effect of estradiol and progesterone in a superfusion model. Prostaglandins Leukot. Med. 1982;8:115-124
27. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal Medicine 1993;328:1069-1075
28. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273:199-208.
29. Magness RB, Rosenfeld CR. Local and systemic estradiol-17 B: effect of uterine and systemic vasodilatation. Am J Physiol 1989;256:E536-E542
30. Resnik R, Killam AP, Battaglia FC, Makowski EL, Meschia G. The stimulation of uterine blood flow by various estrogens. Endocrinology 1974;94:1192-1196
31. Anderson SG, Hackshaw BT, Still JG, Greiss FC Jr. Uterine blood flow and its distribution after chronic estrogen and progesterone administration. Am J Obstet Gynecol 1977;127:138-142
32. 2+ uptake of uterine arterial smooth muscle cells through the potential-sensitive channels. Biol Repord 1987;36:361-68
33. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, Macleod KT. Effect of 17B-oestradiol on contraction, Ca+ current, and intracellular free Ca+ in guinea pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739-45